AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
CARGO Therapeutics Common Stock Statistics
Share Statistics
CARGO Therapeutics Common Stock has 46.03M shares outstanding. The number of shares has increased by 16.93% in one year.
Shares Outstanding | 46.03M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.27% |
Owned by Institutions (%) | n/a |
Shares Floating | 32.06M |
Failed to Deliver (FTD) Shares | 1.48K |
FTD / Avg. Volume | 0.64% |
Short Selling Information
The latest short interest is 6.05M, so 13.14% of the outstanding shares have been sold short.
Short Interest | 6.05M |
Short % of Shares Out | 13.14% |
Short % of Float | 18.86% |
Short Ratio (days to cover) | 25.13 |
Valuation Ratios
The PE ratio is -9.72 and the forward PE ratio is -4.54.
PE Ratio | -9.72 |
Forward PE | -4.54 |
PS Ratio | 0 |
Forward PS | 12.1 |
PB Ratio | 2.35 |
P/FCF Ratio | -10.58 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CARGO Therapeutics Inc. Common Stock.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.35, with a Debt / Equity ratio of 0.
Current Ratio | 19.35 |
Quick Ratio | 19.35 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | -60.29 |
Financial Efficiency
Return on equity (ROE) is -0.24% and return on capital (ROIC) is -22.29%.
Return on Equity (ROE) | -0.24% |
Return on Assets (ROA) | -0.22% |
Return on Capital (ROIC) | -22.29% |
Revenue Per Employee | 0 |
Profits Per Employee | -577.34K |
Employee Count | 170 |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -42.46% in the last 52 weeks. The beta is 0, so CARGO Therapeutics Common Stock's price volatility has been lower than the market average.
Beta | 0 |
52-Week Price Change | -42.46% |
50-Day Moving Average | 16.51 |
200-Day Moving Average | 18.18 |
Relative Strength Index (RSI) | 31.59 |
Average Volume (20 Days) | 230.06K |
Income Statement
Revenue | n/a |
Gross Profit | -3.69M |
Operating Income | -96.71M |
Net Income | -98.15M |
EBITDA | -93.02M |
EBIT | n/a |
Earnings Per Share (EPS) | -2.38 |
Balance Sheet
The company has 405.73M in cash and 28.54M in debt, giving a net cash position of 377.19M.
Cash & Cash Equivalents | 405.73M |
Total Debt | 28.54M |
Net Cash | 377.19M |
Retained Earnings | -145.15M |
Total Assets | 450.96M |
Working Capital | 388.38M |
Cash Flow
In the last 12 months, operating cash flow was -81.16M and capital expenditures -8.99M, giving a free cash flow of -90.16M.
Operating Cash Flow | -81.16M |
Capital Expenditures | -8.99M |
Free Cash Flow | -90.16M |
FCF Per Share | -2.19 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRGX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -21.21% |
FCF Yield | -17.46% |
Analyst Forecast
The average price target for CRGX is $32.5, which is 189.7% higher than the current price. The consensus rating is "Buy".
Price Target | $32.5 |
Price Target Difference | 189.7% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Scores
Altman Z-Score | 7.3 |
Piotroski F-Score | 2 |